Host-directed peptide counters influenza in preclinical study, BioWorld reports
The candidate targets host pathways rather than the virus itself, an approach intended to limit resistance.
PR
By Priya Raman · Science Reporter
Sep 22 12:00 ETSource: BioWorld News
The wire
- 01BioWorld reports preclinical data on a host-directed peptide that counters influenza infection.
- 02Host-targeted antivirals are of interest because they are less prone to viral escape than direct-acting agents, a consideration for future respiratory antiviral pipelines.
- 03The work is preclinical only, with no human dosing, safety or efficacy data reported.
From the source
Read at bioworld.comHost-directed peptide counters flu in preclinical study